Independent fund research. Built on SEC filings.

How we research funds

ETF · Technology Sector · Invesco

IBBQ Holdings: What Invesco Nasdaq Biotechnology ETF Owns

Ticker IBBQ · Since 2021-06-11 · · Holdings as of May 31, 2026

Expense ratio
0.19%$19/yr per $10k
1-yr return
−0.6%as of Dec 2024
Net assets
$67.4Mall share classes
Holdings
261

Bottom line

What does IBBQ hold?

IBBQ held 261 positions as of May 31, 2026. Its largest holding is Invesco Private Prime Fund at 14.20% of the fund, and the top 10 positions add up to 56.6%. By asset type it is 100% stocks, 20% cash & short-term funds.

Updated Jul 28, 2026

IBBQ top 25 holdings

#HoldingType% of fundValue
1 Invesco Private Prime Fund Cash & short-term funds 14.20%$9.6M
2 Gilead Sciences, Inc. Stocks 7.39%$5.0M
3 Vertex Pharmaceuticals Inc. Stocks 7.38%$5.0M
4 Amgen Inc. Stocks 7.10%$4.8M
5 Invesco Private Government Fund Cash & short-term funds 5.48%$3.7M
6 Regeneron Pharmaceuticals, Inc. Stocks 5.08%$3.4M
7 Alnylam Pharmaceuticals, Inc. Stocks 3.19%$2.1M
8 Revolution Medicines, Inc. Stocks 2.48%$1.7M
9 Biogen Inc. Stocks 2.29%$1.5M
10 Illumina, Inc. Stocks 1.98%$1.3M
11 United Therapeutics Corp. Stocks 1.94%$1.3M
12 Royalty Pharma PLC
Royalty Pharma PLC, Class A
Stocks 1.90%$1.3M
13 argenx SE
argenx SE, ADR
Stocks 1.89%$1.3M
14 Insmed Inc. Stocks 1.83%$1.2M
15 Roivant Sciences Ltd. Stocks 1.71%$1.2M
16 Incyte Corp. Stocks 1.53%$1.0M
17 Viatris Inc. Stocks 1.49%$1.0M
18 Moderna, Inc. Stocks 1.48%$999.2K
19 Guardant Health, Inc. Stocks 1.35%$912.0K
20 Neurocrine Biosciences, Inc. Stocks 1.26%$851.8K
21 Jazz Pharmaceuticals PLC Stocks 1.16%$780.4K
22 Ascendis Pharma A/S Stocks 1.10%$739.8K
23 Summit Therapeutics Inc. Stocks 1.08%$729.1K
24 Exelixis, Inc. Stocks 1.04%$702.8K
25 BridgeBio Pharma, Inc. Stocks 1.02%$688.6K

Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 28, 2026

Asset mix

Stocks99.9%
Cash & short-term funds19.7%

Country exposure

BM1.7%
CA0.9%
CH1.2%
DE0.9%
DK1.2%
FR1.5%
GB2.7%
IE1.9%
JE0.2%
KY0.6%